| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QS | Class A Common Stock | Options Exercise | $66,260 | +50,000 | +51% | $1.33* | 147,295 | 02 Aug 2021 | Direct | |
| transaction | QS | Class A Common Stock | Sale | $892,712 | -39,831 | -27% | $22.41 | 107,464 | 02 Aug 2021 | Direct | F1 |
| transaction | QS | Class A Common Stock | Sale | $237,027 | -10,169 | -9.5% | $23.31 | 97,295 | 02 Aug 2021 | Direct | F2 |
| transaction | QS | Class A Common Stock | Options Exercise | $237,700 | +100,000 | +103% | $2.38 | 197,295 | 03 Aug 2021 | Direct | |
| transaction | QS | Class A Common Stock | Sale | $741,670 | -34,181 | -17% | $21.70 | 163,114 | 03 Aug 2021 | Direct | F3 |
| transaction | QS | Class A Common Stock | Sale | $350,420 | -15,619 | -9.6% | $22.44 | 147,495 | 03 Aug 2021 | Direct | F4 |
| transaction | QS | Class A Common Stock | Sale | $4,607 | -200 | -0.14% | $23.04 | 147,295 | 03 Aug 2021 | Direct | F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | QS | Stock Option (right to buy) | Options Exercise | $0 | -50,000 | -25% | $0.000000 | 152,175 | 02 Aug 2021 | Class A Common Stock | 50,000 | $1.33 | Direct | F6 |
| transaction | QS | Stock Option (right to buy) | Options Exercise | $0 | -100,000 | -25% | $0.000000 | 302,175 | 03 Aug 2021 | Class A Common Stock | 100,000 | $2.38 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.985, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.02 to $23.70, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.54 to $21.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.07, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
| F6 | 20% of the shares subject to the option vested and became exercisable on January 1, 2019, and the remaining shares will vest monthly thereafter, subject to the Reporting Person's continued service at each vesting date. |
| F7 | 20% of the shares subject to the option will vest and become exercisable on December 11, 2020, and the remaining shares will vest monthly thereafter, subject to the Reporting Person's continued service at each vesting date. |